BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18501355)

  • 1. Leishmania major: recruitment of Gr-1+ cells into draining lymph nodes during infection is important for early IL-12 and IFN gamma production.
    dos Santos MS; Vaz Cardoso LP; Nascimento GR; Lino Rde S; Dorta ML; de Oliveira MA; Ribeiro-Dias F
    Exp Parasitol; 2008 Jul; 119(3):403-10. PubMed ID: 18501355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
    Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
    Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
    Morris L; Troutt AB; Handman E; Kelso A
    J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy does not interfere with immune response to Leishmania major infection in mice.
    Maioli TU; Carneiro CM; Assis FA; Faria AM
    Cell Immunol; 2007 Sep; 249(1):1-7. PubMed ID: 18093575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
    Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
    Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness.
    Launois P; Swihart KG; Milon G; Louis JA
    J Immunol; 1997 Apr; 158(7):3317-24. PubMed ID: 9120289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early IL-4 production does not predict susceptibility to Leishmania major.
    Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
    Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes.
    Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
    J Immunol; 1997 Feb; 158(3):1246-53. PubMed ID: 9013966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.
    Gessner A; Will A; Vieth M; Schröppel K; Röllinghoff M
    Immunology; 1995 Mar; 84(3):416-22. PubMed ID: 7751025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
    Wershil BK; Theodos CM; Galli SJ; Titus RG
    J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
    Elso C; Kumar B; Smyth G; Foote S; Handman E
    Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-infected C57BL/6 mice mount appropriately polarized and compartmentalized cytokine responses to Litomosoides sigmodontis and Leishmania major but disease progression is altered.
    Lamb TJ; Graham AL; Le Goff L; Allen JE
    Parasite Immunol; 2005 Sep; 27(9):317-24. PubMed ID: 16149989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.
    Heinzel FP; Rerko RM; Hatam F; Locksley RM
    J Immunol; 1993 May; 150(9):3924-31. PubMed ID: 8473741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
    Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
    Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity.
    Heinzel FP; Rerko RM; Hujer AM
    Cell Immunol; 1998 Mar; 184(2):129-42. PubMed ID: 9630839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.